<産業資料/調査レポートの題名> 2022年6月15日

電子ドラッグデリバリーシステムの世界市場:種類別(電子ウェアラブル注入ポンプ、自動注射器、注射ペン、電子吸入器)、疾患別(糖尿病、多発性硬化症、心血管疾患、喘息、COPD)


◆英文タイトル:Global Electronic Drug Delivery Systems Market Size study, by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), by Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) and Regional Forecasts 2019-2026

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1. Electronic Drug Delivery Systems Market, by Type, 2016-2026 (USD Billion)
1.3.2. Electronic Drug Delivery Systems Market, by Indication, 2016-2026 (USD Billion)
1.3.3. Electronic Drug Delivery Systems Market, by Region, 2016-2026 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Electronic Drug Delivery Systems Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Electronic Drug Delivery Systems Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Electronic Drug Delivery Systems Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria (On Demand)
4.4. Regulatory Framework (On Demand)
4.5. Investment Vs Adoption Scenario (On Demand)
4.6. Analyst Recommendation & Conclusion
Chapter 5. Global Electronic Drug Delivery Systems Market, by Type
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Electronic Drug Delivery Systems Market, Sub Segment Analysis
5.3.1. Electronic Wearable Infusion Pumps
5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2. Electronic Autoinjectors
5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.3. Electronic Injection Pens
5.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.4. Electronic Inhalers
5.3.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6. Global Electronic Drug Delivery Systems Market, by Indication
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Electronic Drug Delivery Systems Market, Sub Segment Analysis
6.3.1. Diabetes
6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.2. Multiple Sclerosis
6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.3. Cardiovascular Disease
6.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.4. Asthma & COPD
6.3.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.5. Other Indications
6.3.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 7. Global Electronic Drug Delivery Systems Market, by Regional Analysis
7.1. Electronic Drug Delivery Systems Market, Regional Market Snapshot (2016-2026)
7.2. North America Electronic Drug Delivery Systems Market Snapshot
7.2.1. U.S.
7.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2. Canada
7.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3. Europe Electronic Drug Delivery Systems Market Snapshot
7.3.1. U.K.
7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2. Germany
7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3. Rest of Europe
7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4. Asia Electronic Drug Delivery Systems Market Snapshot
7.4.1. China
7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2. India
7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3. Japan
7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4. Rest of Asia Pacific
7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5. Latin America Electronic Drug Delivery Systems Market Snapshot
7.5.1. Brazil
7.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2. Mexico
7.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6. Rest of The World
7.6.1. Middle East and Africa
7.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Merck Group (Germany)
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Product Summary
8.3.1.4. Recent Developments
8.3.2. Insulet Corporation (US)
8.3.3. Bayer AG (Germany)
8.3.4. Medtronic PLC (Ireland)
8.3.5. Novo Nordisk (Denmark)
8.3.6. United Therapeutics Corporation (US)
8.3.7. AstraZeneca (UK)
8.3.8. Tandem Diabetes Care (US)
8.3.9. Amgen (US)
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.1.6. Research Assumption


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark